IP Library Granted Patent US 7,528,134
Granted Patent B2
US 7,528,134 · App. 10/444,687 · Granted May 5, 2009

Acetamides and benzamides that are useful in treating sexual dysfunction

Assignee: Abbott Laboratories Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,528,134
App. No.
10/444,687
Granted
May 5, 2009
Kind
B2
Abstract

The present invention relates to the use of compounds of formula (I) for the treatment of sexual dysfunction and to compositions containing compounds of formula (I) for the treatment of sexual dysfunction.

Claims (160)

1. A method of treating sexual dysfunction in a mammal comprising administering to said mammal in need of such treatment a therapeutically effective amount of a compound of formula (I)

or a pharmaceutically acceptable salt thereof, wherein

A is selected from the group consisting of aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, heterocycle, and heterocyclealkyl;

L is selected from the group consisting of —N(R 7 )C(O)—, and —C(O)N(R 7 )—, wherein the left end of said —N(R 7 )C(O)—, or —C(O)N(R 7 )—, is attached to A and the right end is attached to D;

D is selected from the group consisting of alkylene, fluoroalkylene, and hydroxyalkylene;

Z is selected from the group consisting of C and CR B , wherein R B is hydrogen;

R A is selected from the group consisting of hydrogen and alkyl;

— is a bond when Z is C and — is absent when Z is CR B ;

B is selected from the group consisting of:

R 1 , R 2 , R 3 , R 4 and R 5 are each independently selected from the group consisting of hydrogen, alkoxy, alkenyl, alkyl, alkylsulfinyl, alkylsulfonyl, alkylthio, alkynyl, alkoxycarbonyl, alkylcarbonyl, alkylcarbonyloxy, carboxy, cyano, formyl, halogen, haloalkoxy, haloalkyl, hydroxy, hydroxyalkyl, mercapto, nitro, —NZ 1 Z 2 , (NZ 3 Z 4 )carbonyl, and (NZ 3 Z 4 )sulfonyl;

Z 1 and Z 2 are each independently selected from the group consisting of hydrogen, alkyl, alkylcarbonyl, alkylsulfonyl, aryl, arylalkyl, arylalkylsulfonyl, arylsulfonyl, and formyl;

Z 3 and Z 4 are each independently selected from the group consisting of hydrogen, alkyl, aryl, and arylalkyl;

X is selected from the group consisting of N(R 6 ), O and S;

Y is selected from the group consisting of C(R 4 ) and N;

R 6 is selected from the group consisting of hydrogen and alkyl; and

R 7 is selected from the group consisting of hydrogen and alkyl.

2. The method according to claim 1 wherein

A is aryl;

B is

Z is N;

— is absent; and

L is —N(R 7 )C(O)—.

3. The method according to claim 1 wherein

A is aryl wherein the aryl is phenyl substituted with 0, 1, 2, 3, 4, or 5 substituents selected from the group consisting of alkenyl, alkoxy, alkoxycarbonyl, alkyl, alkythio, benzyl, cyano, halogen, haloalkoxy, haloalkyl, methylenedioxy, nitro, phenyl, and —NZ 1 Z 2 ;

B is

R 1 , R 2 , R 3 , and R 4 are hydrogen;

Z is CR B ;

— is absent;

D is —CH 2 —; and

L is —N(R 7 )C(O)—.

4. The method according to claim 1 wherein

A is aryl;

B is

Z is CR B ;

— is absent; and

L is —C(O)N(R 7 )—.

5. The method according to claim 1 wherein

A is aryl wherein the aryl is phenyl substituted with 0, 1, 2, 3, 4, or 5 substituents selected from the group consisting of alkenyl, alkoxy, alkoxycarbonyl, alkyl, alkythio, benzyl, cyano, halogen, haloalkoxy, haloalkyl, methylenedioxy, nitro, phenyl, and —NZ 1 Z 2 ;

B is

R 1 is selected from the group consisting of hydrogen, alkyl, cyano, haloalkyl, halogen, nitro, (NZ 3 Z 4 )alkyl, and (NZ 3 Z 4 )carbonyl;

R 2 and R 4 are hydrogen;

R 3 is selected from the group consisting of hydrogen and hydroxy;

Z is CR B ;

R B id hydrogen;

— is absent;

D is —CH 2 —; and

L is —C(O)N(R 7 )—.

6. The method according to claim 1 wherein

A is aryl;

B is

Z is CR B ;

— is absent; and

L is —C(O)N(R 7 )—.

7. The method according to claim 1 wherein

A is aryl wherein the aryl is phenyl substituted with 0, 1, 2, 3, 4, or 5 substituents selected from the group consisting of alkenyl, alkoxy, alkoxycarbonyl, alkyl, alkylthio, benzyl, cyano, halogen, haloalkoxy, haloalkyl, methylenedioxy, nitro, phenyl, and —NZ 1 Z 2 ;

B is

R 1 , R 2 , R 3 , and R 4 are hydrogen;

Z is CR B ;

R B is hydrogen;

— is absent;

D is —CH 2 —; and

L is —C(O)N(R 7 )—.

8. The method according to claim 1 wherein the compound of formula (I) is selected from the group consisting of

N-(3-methylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(4-bromophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2,6-dimethylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2-nitrophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(3-nitrophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2,4-difluorophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2,5-dimethylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2-methylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(4-methylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

2-[4-(2-pyridinyl)-1-piperidinyl]-N-[3-(trifluoromethyl)phenyl]acetamide;

ethyl 4-({[4-(2-pyridinyl)-1-piperidinyl]acetyl}amino)benzoate;

N-(3-chloro-4-methylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2-cyanophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(3-chlorophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

2-[4-(3-cyano-2-pyridinyl)-1-piperidinyl]-N-(3-methylphenyl)acetamide;

N-(4-fluorophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(3,5-dichlorophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2,3-dichlorophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

2-[4-(2-pyridinyl)-1-piperidinyl]-N-[2-(trifluoromethyl)phenyl]acetamide;

N-(3-chloro-4-fluorophenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

2-[4-(2-pyridinyl)-1-piperidinyl]-N-[4-(trifluoromethoxy)phenyl]acetamide;

N-Cyclohexyl-2-(3′,4′,5′,6′-tetrahydro-2′H-[2,4′]bipyridinyl-1′-yl)acetamide;

N-{[4-(2-methoxyphenyl)-1-piperidinyl]methyl}-3-methylbenzamide;

3-methyl-N-{[4-(2-pyridinyl)-1-piperidinyl]methyl}benzamide;

2-(1-{2-[(3-methylphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridiniumn N-oxide;

N-{[4-(2-pyridinyl)-1-piperidinyl]methyl}-3-(trifluoromethyl)benzamide;

3,5-dimethoxy-N-{[4-(2-pyridinyl)-1-piperidinyl]methyl}benzamide;

N-{[4-(2-pyridinyl)-1-piperidinyl]methyl }cyclohexanecarboxamide;

3,4-difluoro-N-{[4-(2-pyridinyl)-1-piperidinyl]methyl}benzamide;

3-chloro-N-{[4-(2-pyridinyl)-1-piperidinyl]methyl}benzamide;

N-(3-methylphenyl)-2-(4-phenyl-1-piperidinyl)acetamide;

3,5-dimethyl-N-{[4-(2-pyridinyl)-1-piperidinyl]methyl}benzamide;

N-(2,6-diethylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

2-[4-(2-pyridinyl)-1-piperidinyl]-N-(2,4,6-trifluorophenyl)acetamide;

N-(4-chloro-2,6-dimethylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

2-[4-(2-pyridinyl)-1-piperidinyl]-N-(2,4,6-trichlorophenyl)acetamide;

2-[4-(3-cyano-2-pyridinyl)-1-piperidinyl]-N-(2,6-dimethylphenyl)acetamide;

N-(2-ethyl-6-methylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2-isopropyl-6-methylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2-chloro-6-methylphenyl)-2-[4-(2-pyridinyl)-1-piperidinyl]acetamide;

N-(2-methoxy-6-methylphenyl)-2-[4-(2-pyridinyl)-1- 1 piperidinyl]acetamide;

2-(1-{2-[(4-fluoro-2-methylphenyl)amino]-2-oxoethyl}-4-piperidinyl)pyridinium N-oxide;

2-(1-{2-[(4-fluoro-3-methylphenyl)amino]-2-oxoethyl}-4-piperidinyl)pyridinium N-oxide;

2-(1-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-4-piperidinyl)pyridinium N-oxide;

2-(1-{2-[(2-fluoro-5-methylphenyl)amino]-2-oxoethyl}-4-piperidinyl)pyridinium N-oxide;

2-(1-{1-methyl-2-[(3-methylphenyl)amino]-2-oxoethyl}-4-piperidinyl)pyridinium N-oxide;

2-(1-{2-[(4-fluorophenyl)amino]-2-oxoethyl}-4-piperidinyl)pyridinium N-oxide;

2-(1-{2-[(2-fluorophenyl)amino]-2-oxoethyl}-4-piperidinyl)pyridinium N-oxide;

2-(1-{2-[(3-chlorophenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-oxo-2-[(2,4,6-tribromo-3-methylphenyl)amino]ethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(4-bromo-3-methylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

N-(3-methylphenyl)-2-(4-pyridin-2-ylpiperidin-1-yl)ethanethioamide;

2-(1-{2-[(3,5-dichlorophenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-[(2,3-dichlorophenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-[(2-methoxy-6-methylphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-{1-[2-(1,1′-biphenyl-3-ylamino)-2-oxoethyl]piperidin-4-yl}pyridinium N-oxide;

2-(1-{2-[(3-ethylphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-{1-[2-(2,3-dihydro-1H-inden-5-ylamino)-2-oxoethyl]piperidin-4-yl}pyridinium N-oxide;

2-{1-[2-oxo-2-(5,6,7,8-tetrahydronaphthalen-1-ylamino)ethyl]piperidin-4-yl}pyridinium N-oxide;

2-(1-{2-[(3-isopropoxyphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-[(3,5-dimethylphenyl)amino]l-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-[(4-bromo-2-methylphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-[1-(2-oxo-2-{[3-(trifluoromethoxy)phenyl]amino}ethyl)piperidin-4-yl]pyridinium N-oxide;

2-(1-{2-[(5-methyl-2-nitrophenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-[(2,6-dimethylphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-[(2,6-dichloro-3-methylphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-[1-(2-{[3-(methylthio)phenyl]amino}-2-oxoethyl)piperidin-4-yl]pyridinium N-oxide;

2-(1-{2-[(5-chloro-2-methylphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-[(2,5-dimethoxyphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-[(3,5-dimethoxyphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-[1-(2-{[3-(dimethylamino)phenyl]amino}-2-oxoethyl)piperidin-4-yl]pyridinium N-oxide;

2-(1-{2-[(3-isopropylphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{2-[(3-chloro-2-methylphenyl)amino]-2-oxoethyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(2,3-dibromo-5-methylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-{1-[(benzoylamino)methyl]piperidin-4-yl}pyridinium N-oxide;

2-(1-{[(4-chloro-3-methylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(4-fluoro-3-methylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-[1-({[3-chloro-4-(trifluoromethoxy)benzoyl]amino}methyl)piperidin-4-yl]pyridinium N-oxide;

2-(1-{[(3-ethoxybenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(3,5-dichlorobenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-[1-({[4-methyl-3-(trifluoromethyl)benzoyl]amino}methyl)piperidin-4-yl]pyridinium N-oxide;

2-(1-{[(3,4-dimethylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(3-chloro-4-fluorobenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(pyridin-2-ylcarbonyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(3,5-dimethylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(3-vinylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(4-bromo-3-methylbenzoyl)amino]methyl}-1,2,3,6-tetrahydropyridin-4-yl)pyridinium N-oxide;

2-(1-{[(3-cyanobenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(4-bromobenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(3-chloro-4-methylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[methyl(3-methylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(3-nitrobenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(2-chloro-5-methylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(3-methoxy-2-methylbenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide;

2-(1-{[(4-chloro-3-methoxybenzoyl)amino]methyl}piperidin-4-yl)pyridinium N-oxide; and

N-(3-methylphenyl)-2-(3-pyridin-2-ylpiperidin-1-yl)acetamide.

9. The method according to claim 1 wherein the compound of formula (I) is 2-(1-{[(3-methylbenzoyl)amino]methyl}-4-piperidinyl)pyridinium N-oxide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2013
From: DAANEN, JEROME F; HAKEEM, AHMED A; KOLASA, TEODOZYJ; MATULENKO, MARK A; MORTELL, KATHLEEN H; PATEL, MEENA V; STEWART, ANDREW O; WANG, XUEQING; XIA, ZHIREN; ZHANG, HENRY Q; BHATIA, PRAMILA A
To: ABBOTT LABORATORIES
Reel/Frame 031167/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030176/0968 →
Continuity (2)
Provisional Application 6038286300 · May 23, 2002
Related Publication 20030229094A1 · Dec 11, 2003